Showing 9391-9400 of 20377 results for "".
- Electronic Medical Tool Helps Clinicians Diagnose MPoxhttps://reachmd.com/news/electronic-medical-tool-helps-clinicians-diagnose-mpox/2462614/Diagnosing infectious conditions can be challenging. Diagnosis is especially challenging for uncommon and emerging infectious diseases for which there’s limited clinical experience. Nevertheless, successfully identifying patients with infectious diseases, especially communicable ones, i
- Too Few Caregivers and Too Many Patients – a Bad Combination for Elderly in Rural Areashttps://reachmd.com/news/too-few-caregivers-and-too-many-patients-a-bad-combination-for-elderly-in-rural-areas/2457474/Too few caregivers and too many patients – a bad combination for elderly in rural areas Elderly people living in rural areas in Norway have higher mortality rates i
- Op-Ed: Practical Advice About Money in Residencyhttps://reachmd.com/news/op-ed-practical-advice-about-money-in-residency/2457398/Background: I went straight through with my education and while I’ve learned about science, humanities, and medicine; one topic that was rarely addressed for its importance was finance. We are trained to be physicians, but we do
- Study Looks at Cancer Prevention from the Perspective of People Experiencing Homelessnesshttps://reachmd.com/news/study-looks-at-cancer-prevention-from-the-perspective-of-people-experiencing-homelessness/2457047/Cancer is twice as likely to affect people experiencing homelessness (PEH) as members of the housed population. The disease is the second most common cause of death among PEH, a group that is underserved when it comes to medical care. At the same time, there i
- Prediagnostic Metabolites Linked To Future Liver Cancer Risk In 12 Cohortshttps://reachmd.com/news/prediagnostic-metabolites-linked-to-future-liver-cancer-risk-in-12-cohorts/2487852/Key Takeaways Across 1,485 metabolites, broad associations were observed for future HCC, while no metabolites remained significant for ICC after false discovery rate correction. Pathway enrichment differed by cancer type, with HCC signals in methylhist
- Pancreatic Ductal Adenocarcinoma with Autoimmune Pancreatitishttps://reachmd.com/news/pancreatic-ductal-adenocarcinoma-with-autoimmune-pancreatitis/2487106/Key Takeaways Type 1 autoimmune pancreatitis in a 50-year-old man was followed over six months by recognition of a pancreatic head mass. EUS-guided fine-needle aspiration of the mass showed pancreatic ductal adenocarcinoma with IgG4-positive plasma cel
- Most Patients With Advanced Cancer Still Aren't Getting Genomic Testinghttps://reachmd.com/news/most-patients-with-advanced-cancer-still-arent-getting-genomic-testing/2486838/Key Takeaways NGS use increased from 2018 to 2022 across all five tumor types, but testing remained incomplete. Longer time to testing was associated with lower socioeconomic status, Black race in several cancers, Hispanic ethnicity in several cancers,
- HER2+ Syngeneic Murine Models for Brain Metastasis and CNS Drug Testinghttps://reachmd.com/news/her2-syngeneic-murine-models-for-brain-metastasis-and-cns-drug-testing/2486329/Investigators report engineering immunocompetent, syngeneic murine mammary carcinoma models to express human HER2 (wild-type and the exon 20 insertion HER2YVMA) and to track spontaneous brain metastasis using a GFP tag. Using both 4T1 (BALB/c background) and EO771 (C57BL/6 background) backb
- Navigating the New COPD Era: Biologics, Guidelines, and Clinical Challengeshttps://reachmd.com/news/navigating-the-new-copd-era-biologics-guidelines-and-clinical-challenges/2484584/Dupilumab has emerged as a practice-changing option for patients with eosinophilic COPD, offering targeted anti–type 2 pathway therapy for those who continue to have frequent exacerbations despite optimized inhaled regimens; this development expands treatment choices for a high-risk
- A Paradigm Shift: Non-Opioid Alternatives in Pain Managementhttps://reachmd.com/news/a-paradigm-shift-non-opioid-alternatives-in-pain-management/2483366/The current landscape of pain management is fraught with challenges. Opioids, while effective for acute and some types of severe pain, carry risks of misuse, addiction, and overdose. These realities have intensified interest in non-opioid approaches that aim to relieve pain while minimizing